Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS)

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 12, 2006, Pages 1404-1411

  Kennard, Betsy ^q   Silva, Susan ^a,l   Vitiello, Benedetto ^b   Curry, John ^a   Kratochvil, Christopher ^g,m   Simons, Anne ^j   Hughes, Jennifer ^k   Feeny, Norah ^c   Weller, Elizabeth ^d,n   Sweeney, Michael ^e   Reinecke, Mark ^h   Pathak, Sanjeev ⁱ   Ginsburg, Golda ^f   Emslie, Graham ^k,m,o   March, John ^a,p  

^a Coordinating Center ^*

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

^j UNIVERSITY OF OREGON   (United States)

^k UNIVERSITY OF TEXAS   (United States)

^l PFIZER

^m Pfizer ^*  (United States)

ⁿ ASTRAZENECA   (United Kingdom)

^o GLAXOSMITHKLINE   (United Kingdom)

^p PFIZER INC   (United States)

^q UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

Depression; Remission; Residual symptoms; Treatment

Indexed keywords

FLUOXETINE; PLACEBO;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BEHAVIOR THERAPY; CHILD PSYCHIATRY; CHILDREN DEPRESSION RATING SCALE REVISED; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE STUDY; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; MOOD DISORDER; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SHORT COURSE THERAPY; SLEEP DISORDER; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEMOGRAPHY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FLUOXETINE; HUMANS; MALE; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33845453247     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000242228.75516.21     Document Type: Article

References (40)

1. Brent D, Holder D, Kolko D et al. (1997), A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 54:877-885
2. Clarke G, Hornbrook M, Lynch F et al. (2002), Group cognitive-behavioral treatment for depressed adolescent offspring of depressed parents in a health maintenance organization. J Am Acad Child Adolesc Psychiatry 41:305-313
3. Clarke G, Rohde P, Lewinsohn P, Hops H, Seeley J (1999), Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry 38:272-279
4. Compton S, March J, Brent D, Albano A, Weersing R, Curry J (2004), Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 43:930-959
5. Cornwall P, Scott J (1997), Partial remission in depressive disorders. Acta Psychiatr Scand 95:265-271
6. Depression Guideline Panel (1993), Clinical Practice Guideline. Depression in Primary Care. Volume 2. Treatment of Major Depression (AHCPR publication no. 93-0551). Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research
7. Emslie G, Heiligenstein J, Wagner K et al. (2002), Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205-1215
8. Emslie G, Rush A, Weinberg W et al. (1997), A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031-1037
9. Faravelli C, Ambonetti A, Pallanti S, Pazzagli A (1986), Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 143:888-891
10. Fava G, Grandi S, Canestrari R, Molnar G (1990), Prodromal symptoms in primary major depressive disorder. J Affect Disord 19:149-152
11. Fava G, Grandi S, Zielezny M, Canestrari R, Morphy M (1994), Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 151:1295-1299
12. Fava G, Fabbri S, Sonino N (2002), Residual symptoms in depression: an emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry 26:1019-1027
13. Frank E, Prien R, Jarrett R et al. (1991), Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48:851-855
14. Guy W (1976), ECDEU Assessment Manual for Psychopharmacology, 2nd ed (DHEW publication no. ABM 76-388). Washington, DC: US Government Printing Office.
15. Judd L, Akiskal H, Maser J et al. (1998), Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50:97-108
16. Kaufman J, Birmaher B, Brent D et al. (1997), Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988
17. Keller M (2004), Remission versus response: the new gold standard of antidepressant care. J Clin Psychiatry 65:53-59
18. Keller M, Boland R (1998), Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 44:348-360
19. Keller M, Hirschfeld R, Hanks D (1997), Double depression: a distinctive subtype of unipolar depression. J Affect Disord 45:65-73
20. Keller M, McCullough J, Klein D et al. (2000), A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342:1462-1470
21. Keller M, Ryan N, Birmaher B et al. (2001), Efficacy of paroxetine in the treatment of adolescent major depression: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 40:762-772
22. Kupfer D (1991), Lessons to be learned from long-term treatment of affective disorders: potential utility in panic disorder. J Clin Psychiatry 52:12-16
23. Lewinsohn P, Clarke G, Hops H, Andrews J (1990), Cognitive-behavioral treatment for depressed adolescents. Behav Ther 21:385-401
24. March J, Silva S, Vitiello B (2006), The Treatment for Adolescents With Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 45:1393-1403
25. Nierenberg A, De Cecco L (2001), Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 62:5-9
26. Nierenberg A, Keefe B, Leslie V et al. (1999), Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 60:221-225
27. Paykel E (1998), Remission and residual symptomatology in major depression. Psychopathology 31:5-14
28. Paykel E, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995), Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25:1171-1180
29. Paykel E, Weissman M (1973), Social adjustment and depression: a longitudinal study. Arch Gen Psychiatry 28:659-663
30. Poznanski E, Mokros H (1996), Children's Depression Rating Scale-Revised (CDRS-R) . Los Angeles: Western Psychological Services
31. Rush AJ, Trivedi M (1995), Treating depression to remission. Psychiatr Ann 25:704-709
32. Shaffer D, Gould MS, Brasic J et al. (1983), A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 40:1228-1231
33. Simons A, Murphy G, Levine J, Wetzel R (1986), Cognitive therapy and pharmacotherapy for depression: sustained improvement over one year. Arch Gen Psychiatry 43:43-48
34. TADS (2003), The Treatment for Adolescents With Depression Study (TADS): rationale, design, andmethods. J Am Acad Child Adolesc Psychiatry 42:531-542
35. TADS (2004), Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292:807-820
36. TADS (2005), The Treatment for Adolescents With Depression Study (TADS): demographics and clinical characteristics. J Am Acad Child Adolesc Psychiatry 44:28-40
37. Thase M, Simons A, McGeary J et al. (1992), Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 149:1046-1052
38. Vostanis P, Feehan C, Grattan E, Bickerton W (1996), A randomised controlled outpatient trial of cognitive-behavioural treatment for children and adolescents with depression: 9-month follow-up. J Affect Disord 40:105-116
39. Wagner K, Robb A, Findling R, Jin J, Gutierrez M, Heydorn W (2004), A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 161:1079-1083
40. Wood A, Harrington R, Moore A (1996), Controlled trial of a brief cognitive-behavioral intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry 37:737-746